Genomic computation platform launches on Microsoft Azure

By Vassia Barba contact

- Last updated on GMT

(Image: Getty/Artystarty)
(Image: Getty/Artystarty)

Related tags: Cloud software, Cloud applications, cloud based software, analytical, Analytical chemistry, Analytical testing

EPAM Cloud Pipeline, a cloud software application, is available on Microsoft Azure to support developers manage ‘constantly changing’ demands in analytics and modeling.

EPAM Systems, a software services developing company, announced the launch of its EPAM Cloud Pipeline solution, which aims to accelerate drug discovery clinical research.

The application is available on Amazon and Google Cloud, and it will now be made available for purchase on the Microsoft Azure platform, an online marketplace created by Microsoft for buying and selling of software services.

EPAM Cloud Pipeline will be open-source, and will utilize machine learning capabilities, allowing scientists to build and run customized scripts and workflows required to support genomics analysis, modeling, and simulation operations during clinical research.

According to EPAM, the software will function as a combination of a cloud application (leveraging Azure’s computing and storage resources) and on-premises software installed on the users’ computers.

Greg Killian, head of Life Sciences business unit of EPAM, commented that the service’s intuitive interface is expected to help scientists manage the ‘constantly changing’ demands in analytics and modeling, without requiring specialized IT skills.

According to Killian, the software regards researchers whose studies require significant computational power and storage capacity, aiming to help them save valuable time and lower the costs of their research.

On his side, Sajan Parihar, senior director of the Microsoft Azure, explained that the platform will provide EPAM with the opportunity to reach more healthcare and life sciences customers.

Related news

Show more

Related products

show more

Liver Disease Capabilities

Liver Disease Capabilities

Q² Solutions | 01-Oct-2020 | Clinical Study

We integrate therapeutic insights, state-of-the-art technologies, best-in-class methods and quality systems to optimize NAFLD & NASH study design,...

CAR-T Cell Therapy

CAR-T Cell Therapy

Q² Solutions | 01-Sep-2020 | Clinical Study

Cell therapy involves the transfer of genetically altered cells into a patient. As a global central laboratory services organization, we provide testing...

Laboratory Solutions for COVID-19 Clinical Trials

Laboratory Solutions for COVID-19 Clinical Trials

Q² Solutions | 10-Jun-2020 | Clinical Study

As a leading laboratory services organization for trials across the globe, we are proud to partner with clients to support COVID-19 clinical trials. Our...

Related suppliers

Follow us

Products

View more

Webinars